Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Osteoporosis International

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1007/s00198-004-1623-4PMID 15103452
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• International comparison of hip fracture rates in 1988–89

  2005cited by this paper
• The risk and burden of vertebral fractures in Sweden

  2004cited by this paper
• Excess mortality after hospitalisation for vertebral fracture

  2004cited by this paper
• Cost-equivalence of different osteoporotic fractures

  2003cited by this paper
• The Skeletal Response to Teriparatide Is Largely Independent of Age, Initial Bone Mineral Density, and Prevalent Vertebral Fractures in Postmenopausal Women With Osteoporosis

  2003cited by this paper
• Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial.

  2003cited by this paper
• The components of excess mortality after hip fracture.

  2003cited by this paper
• Treatment of established osteoporosis: a systematic review and cost-utility analysis.

  2002cited by this paper
• Direct Medical Costs Attributable to Osteoporotic Fractures

  2002cited by this paper
• International Variations in Hip Fracture Probabilities: Implications for Risk Assessment

  2002cited by this paper
• Economic Evaluation of Interventions for Osteoporosis

  2002cited by this paper
• Osteoporosis in Men and Women: A Story About Bone Mineral Density Thresholds and Hip Fracture Risk

  2002cited by this paper
• Intervention thresholds for osteoporosis.

  2002cited by this paper
• Inpatient hospital and post-acute care for vertebral fractures in women.

  2002cited by this paper
• Meta-analyses of therapies for postmenopausal osteoporosis. I. Systematic reviews of randomized trials in osteoporosis: introduction and methodology.

  2002cited by this paper
• Costs and quality of life associated with osteoporosis related fractures: Results from a Swedish survey

  2002cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• Meta-Analyses of Therapies for Postmenopausal Osteoporosis

  2002cited by this paper
• The Relationship Between Bone Density and Incident Vertebral Fracture in Men and Women

  2002cited by this paper
• Diagnosis of osteoporosis and assessment of fracture risk.

  2002influential reference
• Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.

  2001cited by this paper
• Preference for fractures and other glucocorticoid-associated adverse effects among rheumatoid arthritis patients.

  2001cited by this paper
• Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

  2001cited by this paper
• The Burden of Osteoporotic Fractures: A Method for Setting Intervention Thresholds

  2001influential reference
• Cost-Effectiveness of Preventing Hip Fracture in the General Female Population

  2001cited by this paper
• Preferences for Fractures and Other Glucocorticoid-Associated Adverse Effects among Rheumatoid Arthritis Patients

  2001cited by this paper
• NICE: faster access to modern treatments? Analysis of guidance on health technologies

  2001cited by this paper
• Impact of Hip and Vertebral Fractures on Quality-Adjusted Life Years

  2001cited by this paper
• Statin therapy - what now?

  2001cited by this paper
• Diagnosis of Osteoporosis and Fracture Threshold in Men

  2001cited by this paper
• At what coronary risk level is it cost-effective to initiate cholesterol lowering drug treatment in primary prevention?

  2001influential reference
• The effect of risedronate on the risk of hip fracture in elderly women.

  2001influential reference
• Long-Term Risk of Osteoporotic Fracture in Malmö

  2000influential reference
• The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women: Results From the MORE Randomized Trial

  2000cited by this paper
• A computer model to analyse the cost-effectiveness of hormone replacement therapy - a revised version

  2000cited by this paper
• INTERNATIONAL OSTEOPOROSIS FOUNDATION. AN UPDATE ON THE DIAGNOSIS AND ASSESSMENT OF OSTEOPOROSIS WITH DENSITOMETRY

  2000cited by this paper
• An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation.

  2000cited by this paper
• Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis

  2000cited by this paper
• Risk of Mortality Following Clinical Fractures

  2000cited by this paper
• Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus; results from the DIGAMI study.

  2000cited by this paper
• Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group.

  2000cited by this paper
• Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis

  2000cited by this paper
• Fracture Incidence in Olmsted County, Minnesota: Comparison of Urban with Rural Rates and Changes in Urban Rates Over time

  1999cited by this paper
• A COMPUTER MODEL TO ANALYZE THE COST-EFFECTIVENESS OF HORMONE REPLACEMENT THERAPY

  1999cited by this paper
• Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.

  1999cited by this paper
• Effect and Offset of Effect of Treatments for Hip Fracture on Health Outcomes

  1999influential reference
• The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.

  1999cited by this paper
• Health-related Quality of Life in Economic Evaluations for Osteoporosis

  1999cited by this paper
• Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group.

  1999cited by this paper
• Mortality after all major types of osteoporotic fracture in men and women: an observational study.

  1999influential reference
• Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Executive summary.

  1998cited by this paper
• Estimating the Costs of Hip Fracture and Potential Savings

  1998cited by this paper
• Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.

  1998cited by this paper
• Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention.

  1998cited by this paper
• Lifetime Risk of Hip Fractures is Underestimated

  1998cited by this paper
• Hip Fracture Prediction in Elderly Men and Women: Validation in the Rotterdam Study

  1998cited by this paper
• The Association of Radiographically Detected Vertebral Fractures with Back Pain and Function: A Prospective Study

  1998cited by this paper
• Accounting for future costs in medical cost-effectiveness analysis.

  1997cited by this paper
• Accounting for Future Costs in Medical Cost-Effectiveness Analysis

  1997cited by this paper
• Incorporating Future Costs in Medical Cost-Effectiveness Analysis

  1997cited by this paper
• The cost of a hip fracture. Estimates for 1,709 patients in Sweden.

  1997cited by this paper
• 96153999 Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

  1996influential reference
• Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table.

  1996cited by this paper
• Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

  1996cited by this paper
• The Sheffield table for primary prevention of coronary heart disease: corrected.

  1996cited by this paper
• Cost-effectiveness of fracture prevention in established osteoporosis.

  1996influential reference
• Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

  1996cited by this paper
• Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

  1996cited by this paper
• Assessment of fracture risk and its application to screening for postmenopausal osteoporosis (WHO Technical Report Series No 843)

  1995cited by this paper
• Cost-effectiveness of preventing hip fractures in the elderly population using vitamin D and calcium.

  1995cited by this paper
• Cost-effectiveness of fracture prevention in established osteoporosis

  1995cited by this paper
• Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

  1995cited by this paper
• Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.

  1994cited by this paper
• Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women

  1994cited by this paper
• Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report

  1994cited by this paper
• The variable incidence of hip fracture in Southern Europe: The MEDOS study

  1994cited by this paper
• Symptomatic fracture incidence in elderly men and women: The Dubbo osteoporosis epidemiology study (DOES)

  1994cited by this paper
• Population-based study of survival after osteoporotic fractures.

  1993cited by this paper
• The apparent incidence of hip fracture in Europe: A study of national register sources

  1992cited by this paper
• Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture.

  1992cited by this paper
• What is the true mortality of hip fractures?

  1991cited by this paper
• Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study.

  1987cited by this paper
• Postmenopausal estrogens in prevention of osteoporosis. Benefit virtually without risk if cardiovascular effects are considered.

  1986cited by this paper
• Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen.

  1980cited by this paper
• ANTIBIOTIC TREATMENT AND NEONATAL GROUP-B STREPTOCOCCAL INFECTION

  1978cited by this paper

• Sociodemographic Differences in the Epidemiology and Management of Osteoporosis-Related Vertebral Fractures

  2025cites this paper
• Frequency of Osteoporosis-Related Fractures in the Kingdom of Bahrain

  2024cites this paper
• Clinical impact on dental implant survival in patients taking antiresorptive medications: A systematic review and meta-analysis.

  2023cites this paper
• FRAX-based intervention thresholds for men in the Russian Federation: Expert consensus of the Russian association on osteoporosis

  2023cites this paper
• Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review

  2023cites this paper
• The effectiveness of screening to identify patients with osteoporosis/high risk of fractures in primary health care

  2022cites this paper
• FRAX-based intervention thresholds in eight Eurasian countries: Armenia, Belarus, Georgia, Kazakhstan, the Kyrgyz Republic, Moldova, the Russian Federation, and Uzbekistan

  2021cites this paper
• Osteoporosis Screening and Diagnosis

  2020cites this paper
• Bone mineral density reference values in Singaporean adults and comparisons for osteoporosis establishment – The Yishun Study

  2020cites this paper
• A systematic review of the indirect and social costs studies in fragility fractures

  2020cites this paper
• Treatment Strategies in Osteoporosis

  2019cites this paper
• Epidemiology of Osteoporosis

  2019cites this paper
• A brief history of FRAX

  2018cites this paper
• Effect of improved medication adherence on health care costs in osteoporosis patients

  2018cites this paper
• Cost‐Effectiveness of Osteoporosis Treatment

  2018cites this paper
• Association of Insulin Resistance with Bone Strength and Bone Turnover in Menopausal Chinese-Singaporean Women without Diabetes

  2018cites this paper
• PERFIL DA COMPOSIÇÃO CORPORAL E DENSIDADE MINERAL ÓSSEA DE TABAGISTAS EM UM CENTRO DE REFERÊNCIA EM REABILITAÇÃO E ASSISTÊNCIA À SAÚDE.

  2018cites this paper
• Bone mineral density measurements in vertebral specimens and phantoms using dual-layer spectral computed tomography

  2017cites this paper
• Quantitative analysis of efficacy and associated factors of calcium intake on bone mineral density in postmenopausal women

  2017cites this paper
• Prediction and Utility of a clinical fracture risk score in administrative claims

  2017cites this paper
• Time course of osteoporotic vertebral fractures by magnetic resonance imaging using a simple classification: a multicenter prospective cohort study

  2017cites this paper
• Fracture Risk Assessment in Patients With Diabetes Mellitus.

  2017cites this paper
• Pre-fracture nutritional status is predictive of functional status at discharge during the acute phase with hip fracture patients: A multicenter prospective cohort study.

  2017cites this paper
• Evaluation on the cost-effective threshold of osteoporosis treatment on elderly women in China using discrete event simulation model

  2017cites this paper
• Osteoporosis in men: findings from the Osteoporotic Fractures in Men Study (MrOS)

  2016cites this paper
• PROOF COVER SHEET

  2015cites this paper
• FRAX and fracture prediction without bone mineral density

  2015cites this paper
• Cost-effectiveness analysis of treatment of osteoporotic fractures in relation to FRAX algorithm in a sample of Polish population.

  2015cites this paper
• Managing osteoporosis with FRAX® in Australia: proposed new treatment thresholds from the 45&Up Study cohort.

  2014cites this paper
• Simulation of the behaviour of the L1 vertebra for different material properties and loading conditions

  2013cites this paper
• Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis

  2013cites this paper
• [Utilization of physiotherapy services for traumatic disorders of the lower extremity in ambulatory care].

  2013cites this paper
• Inflammatory bowel disease and the risk of fracture after controlling for FRAX

  2013cites this paper
• Updated fracture incidence rates for the Italian version of FRAX®

  2013influential citation
• What’s in a name revisited: should osteoporosis and sarcopenia be considered components of “dysmobility syndrome?”

  2013cites this paper
• A simple intervention for improving the implementation rate of a recommended osteoporosis treatment after hip fracture.

  2013cites this paper
• Progressively increasing fracture risk with advancing age after initial incident fragility fracture: The Tromsø Study

  2013cites this paper
• Osteoporosis in the European Union: medical management, epidemiology and economic burden

  2013cites this paper
• The savings factor between treatment of osteoporosis and treatment of subsequent osteoporotic fracture in the Netherlands.

  2013cites this paper
• Fracture Risk Assessment: The Development and Application of FRAX®

  2013cites this paper
• 55. Cost-Effectiveness of Osteoporosis Treatment

  2013cites this paper
• Clinical characteristics influence in vitro action of 1,25‐dihydroxyvitamin D3 in human marrow stromal cells

  2012cites this paper
• Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland

  2012cites this paper
• Cost Effectiveness of the German Screen-and-Treat Strategy for Postmenopausal Osteoporosis

  2012cites this paper
• Prediction of Biomechanical Properties of Trabecular Bone in MR Images With Geometric Features and Support Vector Regression

  2011cites this paper
• Effects of non-optimal focusing on dual-frequency ultrasound measurements of bone

  2011cites this paper
• Osteoporosis: burden, health care provision and opportunities in the EU

  2011cites this paper
• Femoral neck bone mineral density and 10-year absolute fracture risk in a national representative sample of Bulgarian women aged 50 years and older

  2011cites this paper
• An Analysis of the Changes in Bone Mineral Density in Long-Stay Patients of a Geriatric Hospital in Relation to Physical Therapy

  2011cites this paper
• Epidemiology and Economic Burden of Osteoporosis in South Korea.

  2011cites this paper
• Principles of health economics and application to rheumatic disorders

  2011cites this paper
• Low-energy distal radius fractures in middle-aged and elderly men and women—the burden of osteoporosis and fracture risk

  2010cites this paper
• The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis

  2010cites this paper
• The Utility and Limitations of FRAX: A US Perspective

  2010cites this paper
• The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX®

  2010cites this paper
• Medical Service Utilization with Osteoporosis

  2010cites this paper
• Prediction of Vertebral Fractures Is Specific for Gender and Site of Bone Mineral Density Measurement

  2010cites this paper
• Cost-Effectiveness of Interventions to Reduce Osteoporosis-Related Fractures in Men: Current Data, Controversies, and Challenges

  2010cites this paper
• The FRAX tool in French women: How well does it describe the real incidence of fracture in the OFELY cohort

  2010cites this paper
• Dual-Energy X-ray Absorptiometry (DXA) in Men

  2010cites this paper
• Meta-analysis: Excess Mortality After Hip Fracture Among Older Women and Men

  2010cites this paper
• How to decide who to treat.

  2009cites this paper
• FRAX and its applications to clinical practice.

  2009cites this paper
• Approaches to the targeting of treatment for osteoporosis

  2009cites this paper
• Ökonomische Konzepte zur Erfassung der Krankheitskosten von Osteoporose: Österreich im internationalen Vergleich

  2009influential citation
• [Economic concepts for measuring the costs of illness of osteoporosis: an international comparison].

  2009cites this paper
• A perspective on male osteoporosis.

  2009cites this paper
• The effects of a FRAX® revision for the USA

  2009cites this paper
• The incidence and risk of hip fracture in Poland

  2009cites this paper
• Aktuelle Diagnostik und Therapie der Osteoporose auf der Basis der „European Guidance 2008“

  2009cites this paper
• Epidemiology of osteoporosis related fractures in Hungary from the nationwide health insurance database, 1999–2003

  2008cites this paper
• Cost-effective osteoporosis treatment thresholds: the United States perspective

  2008influential citation
• Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA

  2008cites this paper
• The cost-effectiveness of alendronate in the management of osteoporosis.

  2008cites this paper
• Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK

  2008cites this paper
• European guidance for the diagnosis and management of osteoporosis in postmenopausal women

  2008cites this paper
• CHAPTER 3 – The Economics of Osteoporosis

  2008cites this paper
• [Treatment of osteoporosis according to the "European Guidance 2008". Fracture-oriented--economical--cost-effective].

  2008cites this paper
• Cost effectiveness of ultrasound and bone densitometry for osteoporosis screening in post-menopausal women

  2008cites this paper
• ЄВРОПЕЙСЬКІ РЕКОМЕНДАЦІЇ З ДІАГНОСТИКИ ТА ВЕДЕННЯ ОСТЕОПОРОЗУ У ЖІНОК В ПОСТМЕНОПАУЗАЛЬНОМУ ПЕРІОДІ

  2008cites this paper
• European guidance for the diagnosis and management of osteoporosis in postmenopausal women

  2008cites this paper
• Evaluation of Risk for Osteoporotic Fracture

  2008cites this paper
• First update of the Lebanese guidelines for osteoporosis assessment and treatment.

  2008cites this paper
• Therapie der Osteoporose nach der „European Guidance 2008“

  2008cites this paper
• Inhibition of bone turnover by milk intake in postmenopausal women

  2008cites this paper
• Structural basis of growth-related gain and age-related loss of bone strength

  2008cites this paper
• Health economics of osteoporosis.

  2008cites this paper
• Prevention and treatment of postmenopausal osteoporosis.

  2008cites this paper
• Ökonomische Aspekte der Osteoporose - eine Einführung

  2007cites this paper
• The societal burden of osteoporosis in Sweden.

  2007cites this paper
• An evaluation of densitometric vertebral fracture assessment in men

  2007cites this paper
• Vers une évaluation globale du risque fracturaire

  2007cites this paper
• Mise au point Vers une évaluation globale du risque fracturaire Devising global strategies for fracture-risk evaluation ◊

  2007cites this paper
• Osteoporosis in elderly women in primary health care

  2007cites this paper
• The cost-effectiveness of bisphosphonates in postmenopausal women based on individual long-term fracture risks.

  2007cites this paper
• Excess mortality following hip fracture: the role of underlying health status

  2007cites this paper
• Selecting Patients for Osteoporosis Therapy

  2007cites this paper
• Effectiveness of antiresorptive agents in the prevention of recurrent hip fractures

  2007cites this paper
• Cost-effectiveness modeling research of pharmacologic therapy to prevent osteoporosis-related fractures

  2007cites this paper
• Devising global strategies for fracture-risk evaluation.

  2007cites this paper